|1.||Small, Eric J: 10 articles (02/2011 - 12/2003)|
|2.||Itoh, Kyogo: 8 articles (04/2011 - 02/2004)|
|3.||Fizazi, Karim: 7 articles (01/2016 - 09/2004)|
|4.||Kelly, W Kevin: 7 articles (07/2015 - 11/2003)|
|5.||Yamada, Akira: 7 articles (04/2011 - 06/2004)|
|6.||Smith, David C: 6 articles (05/2011 - 04/2003)|
|7.||Noguchi, Masanori: 6 articles (04/2011 - 02/2004)|
|8.||Petrylak, Daniel P: 6 articles (06/2006 - 08/2002)|
|9.||Habuchi, Tomonori: 5 articles (10/2015 - 10/2005)|
|10.||Beuzeboc, Philippe: 5 articles (07/2015 - 05/2005)|
|1.||Prostatic Neoplasms (Prostate Cancer)
01/01/1996 - "With now over 10 years mean follow-up for this series of patients, we conclude that adjuvant estramustine is beneficial for prostate cancer patients receiving definitive irradiation. "
02/01/1993 - "Adjuvant estramustine phosphate was beneficial in patients with prostate cancer and pelvic node involvement who received irradiation as definitive treatment."
03/01/1984 - "Estracyt Research Group in Japan concluded that Estracyt was effective in 38% of reactivated prostatic cancer patients (15% (I-C, I-B), 23% (I-A, O-B, O-C]. "
05/01/1988 - "[Stage D1 prostatic cancer benefited by a single regimen of Estracyt]."
01/31/1982 - "[Total remission of prostatic cancer following treatment with Estracyt]."
01/01/1991 - "Estracyt was effective for untreated prostatic carcinoma but the problems such as recurrence of progression and side effects require further examination."
04/01/1976 - "Estramustine phosphate has been useful in the treatment of advanced carcinoma of the prostate. "
01/01/1985 - "We conclude that estramustine phosphate retards the growth of various cells, and that studies of other potential fields of application of the drug (aside from prostatic carcinoma) is justified."
01/01/1980 - "A preliminary report is presented of prospective, randomized study with continuous and intermittent oral Estracyt treatment in patients with prostatic carcinoma. "
03/01/1977 - "In a previous study, 50 patients with prostatic carcinoma were given continuous oral estramustine phosphate at a dose of 15 mg/kg/day. "
11/01/2007 - "In phase II trials of patients with cancer, response to microtubule inhibitors increases when these drugs are combined with estramustine. "
11/01/1987 - "Immunofluorescent studies of the anti-microtubule effects of the anti-cancer drug estramustine."
12/01/1985 - "Fluorescence-microscopic studies with dansylated estramustine (DnsEM) has permitted investigation of the mechanism of estramustine (EM) uptake in live human prostatic tumor cells (DU 145). "
01/01/2013 - "Estramustine may trigger suicidal death of cancer cells. "
11/01/2010 - "Among the six human androgen-independent tumors treated with estramustine alone, two highly sensitive models, two intermediate responding tumors, and two resistant models were observed. "
12/01/2011 - "• There were no statistically significant changes in the QLQ-C30 scales during treatment except in the case of patients receiving DOC and estramustine, who experienced a significant decrease in pain. "
04/01/2000 - "Re: Estramustine phosphate withdrawal syndrome with dramatic pain relief."
09/01/1999 - "Estramustine phosphate withdrawal syndrome with dramatic pain relief."
07/01/1995 - "In addition to producing similar objective response rates to other established agents, estramustine phosphate improves the subjective status of many patients and has been shown to reduce the intensity of pain and improve the performance status of patients.(ABSTRACT TRUNCATED AT 250 WORDS)"
11/01/1986 - "In this study, Estracyt showed 80% improvement of dysuria, 60% of nykturia, 35% of pain and 55% of general condition. "
01/01/2002 - "In this study, the effect of irradiation, alone and in combination with the antimicrotubule drug estramustine (EaM), was investigated in vitro using the BT4C rat glioma cell line, and in vivo the BT4C rat intracerebral glioma model was used. "
04/01/2000 - "Drug-induced apoptosis by anti-microtubule agent, estramustine phosphate on human malignant glioma cell line, U87MG; in vitro study."
01/01/1999 - "Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells."
10/01/1996 - "These studies have demonstrated that estramustine has potent antiproliferative effects against malignant glioma both in vitro and in vivo. "
11/01/1989 - "In conclusion, certain cultured malignant glioma cells display significant uptake, retention and metabolism of estramustine phosphate and further studies are indicated to assess the clinical implications of these findings."
|5.||Etoposide (VP 16)
|9.||Vinblastine (Vinblastine Sulfate)
|2.||Drug Therapy (Chemotherapy)
|4.||Combination Drug Therapy (Combination Chemotherapy)